154 related articles for article (PubMed ID: 9813145)
21. Thrombin-induced association of SHP-2 with multiple tyrosine-phosphorylated proteins in human platelets.
Edmead CE; Crosby DA; Southcott M; Poole AW
FEBS Lett; 1999 Oct; 459(1):27-32. PubMed ID: 10508911
[TBL] [Abstract][Full Text] [Related]
22. Molecular dynamics simulations on the free and complexed N-terminal SH2 domain of SHP-2.
Wieligmann K; Pineda De Castro LF; Zacharias M
In Silico Biol; 2002; 2(3):305-11. PubMed ID: 12542415
[TBL] [Abstract][Full Text] [Related]
23. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
Qin C; Wavreille AS; Pei D
Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
[TBL] [Abstract][Full Text] [Related]
24. Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates.
Hua CT; Gamble JR; Vadas MA; Jackson DE
J Biol Chem; 1998 Oct; 273(43):28332-40. PubMed ID: 9774457
[TBL] [Abstract][Full Text] [Related]
25. Evidence of a role for SHP-1 in platelet activation by the collagen receptor glycoprotein VI.
Pasquet JM; Quek L; Pasquet S; Poole A; Matthews JR; Lowell C; Watson SP
J Biol Chem; 2000 Sep; 275(37):28526-31. PubMed ID: 10871605
[TBL] [Abstract][Full Text] [Related]
26. A model of activation of the protein tyrosine phosphatase SHP-2 by the human leptin receptor.
Löthgren A; McCartney M; Rupp Thuresson E; James SR
Biochim Biophys Acta; 2001 Feb; 1545(1-2):20-9. PubMed ID: 11342028
[TBL] [Abstract][Full Text] [Related]
27. Sustained stimulation of platelet thrombin receptor is associated with tyrosine dephosphorylation of a novel p67 peptide in a manner regulated by extracellular calcium.
Karim ZA; Mukhopadhyay S; Ramars AS; Dash D
Biochim Biophys Acta; 2004 Aug; 1693(2):147-57. PubMed ID: 15313016
[TBL] [Abstract][Full Text] [Related]
28. Regulation of Src homology 2-containing tyrosine phosphatase 1 during activation of human neutrophils. Role of protein kinase C.
Brumell JH; Chan CK; Butler J; Borregaard N; Siminovitch KA; Grinstein S; Downey GP
J Biol Chem; 1997 Jan; 272(2):875-82. PubMed ID: 8995376
[TBL] [Abstract][Full Text] [Related]
29. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2.
Barford D; Neel BG
Structure; 1998 Mar; 6(3):249-54. PubMed ID: 9551546
[TBL] [Abstract][Full Text] [Related]
30. Platelet factor XIII becomes active without the release of activation peptide during platelet activation.
Muszbek L; Polgár J; Boda Z
Thromb Haemost; 1993 Mar; 69(3):282-5. PubMed ID: 8097064
[TBL] [Abstract][Full Text] [Related]
31. Regulation of SHP-1 tyrosine phosphatase in human platelets by serine phosphorylation at its C terminus.
Jones ML; Craik JD; Gibbins JM; Poole AW
J Biol Chem; 2004 Sep; 279(39):40475-83. PubMed ID: 15269224
[TBL] [Abstract][Full Text] [Related]
32. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
Chen WL; Harris DL; Joyce NC
Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes.
Pugazhenthi S; Tanha F; Dahl B; Khandelwal RL
Arch Biochem Biophys; 1996 Nov; 335(2):273-82. PubMed ID: 8914924
[TBL] [Abstract][Full Text] [Related]
34. Participation of calpain in protein-tyrosine phosphorylation and dephosphorylation in human blood platelets.
Ariyoshi H; Oda A; Salzman EW
Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):511-4. PubMed ID: 7749863
[TBL] [Abstract][Full Text] [Related]
35. Interaction of Ca2+ and protein phosphorylation in the rabbit platelet release reaction.
Lyons RM; Shaw JO
J Clin Invest; 1980 Feb; 65(2):242-55. PubMed ID: 6985917
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the specificity of bacterially expressed cytoplasmic protein-tyrosine phosphatases SHP and SH-PTP2 towards synthetic phosphopeptide substrates.
Dechert U; Affolter M; Harder KW; Matthews J; Owen P; Clark-Lewis I; Thomas ML; Aebersold R; Jirik FR
Eur J Biochem; 1995 Aug; 231(3):673-81. PubMed ID: 7649167
[TBL] [Abstract][Full Text] [Related]
37. The effects of calpeptin (a calpain specific inhibitor) on agonist induced microparticle formation from the platelet plasma membrane.
Yano Y; Shiba E; Kambayashi J; Sakon M; Kawasaki T; Fujitani K; Kang J; Mori T
Thromb Res; 1993 Sep; 71(5):385-96. PubMed ID: 8236165
[TBL] [Abstract][Full Text] [Related]
38. Distinct substrate specificities and functional roles for the 78- and 76-kDa forms of mu-calpain in human platelets.
Schoenwaelder SM; Kulkarni S; Salem HH; Imajoh-Ohmi S; Yamao-Harigaya W; Saido TC; Jackson SP
J Biol Chem; 1997 Oct; 272(40):24876-84. PubMed ID: 9312088
[TBL] [Abstract][Full Text] [Related]
39. Tyrosine phosphorylation of an SH2-containing protein tyrosine phosphatase is coupled to platelet thrombin receptor via a pertussis toxin-sensitive heterotrimeric G-protein.
Li RY; Gaits F; Ragab A; Ragab-Thomas JM; Chap H
EMBO J; 1995 Jun; 14(11):2519-26. PubMed ID: 7781604
[TBL] [Abstract][Full Text] [Related]
40. Bruton's tyrosine kinase is a substrate of calpain in human platelets.
Mukhopadhyay S; Ramars AS; Ochs HD; Dash D
FEBS Lett; 2001 Sep; 505(1):37-41. PubMed ID: 11557038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
